Despite impressive strides, multidetector CT scanner technology could still use some tweaking to maximize its utility, according to a speaker at the seventh annual Symposium on Multidetector-Row CT in San Francisco.
Despite impressive strides, multidetector CT scanner technology could still use some tweaking to maximize its utility, according to a speaker at the seventh annual Symposium on Multidetector-Row CT in San Francisco.
"We need more flexibility in handling the imaging data," said Dr. Willi Kalender, a radiology researcher at the University of Erlangen in Germany. "These are not necessarily features that are technology-driven. We have to ask ourselves what is needed clinically."
Tasked to come up with five features still needed to optimize multislice CT, Kalendar first outlined general goals for CT systems: shorter scan times for reliable cardiac imaging and larger z-axis coverage for perfusion measurements in the brain, heart, and lungs.
Achieving those goals means developing a system with multiple sources and detectors, for higher peak x-ray power and shorter scan times, he said. Such a CT system, whether using multiple or segmented detectors, would also be capable of higher spatial resolution for fluoroscopy and radiography.
A third item on the top five wish list would be a system with more tissue parameters to allow radiologists to escape the Hounsfield unit "cage," Kalendar said. His fourth desirable feature was interactively variable isotropic spatial resolution, which would be particularly useful in cardiac imaging.
Last but not least, Kalender would like to see CT established as a low-dose modality.
"With the advent of automatic exposure control, CT already is a low-dose modality, but that is not the widely held perception," he said. "We need to change that."
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.